
Amgen’s Kyprolis has been given another endorsement by the FDA as a multiple myeloma treatment – its second in six …

The FDA has accepted for priority review Amgen’s supplemental new drug application for Kyprolis (carfilzomib) for patients with relapsed multiple …

Results from a Phase III study of a new multiple myeloma offering have found promising results for a treatment that …
Jager-van Dijk is new Arletta Pharma Solutions CEOÂ
Tridem begins phase Ib trial of Parkinson’s disease vaccine
Trio become latest Symbiosis commercial additions
UK immunoglobulin supply faces growing pressure, report warns

